Key result
Clinical pharmacist integration matches surgeon-only perioperative pain control while reducing opioid use.
Why the study?
The study was conducted to assess the impact of integrating an evidence-based clinical pharmacist practitioner model into the perioperative orthopedic surgery clinical pathway on pain management and surgical team satisfaction.
Does integrating a clinical pharmacist practitioner improve perioperative pain management and reduce opioid use in patients undergoing orthopedic surgery?
Does integrating a clinical pharmacist practitioner improve perioperative pain management and reduce opioid use in patients undergoing orthopedic surgery?
Integrating a clinical pharmacist practitioner into orthopedic surgery pathways can reduce perioperative opioid prescribing while maintaining adequate pain control and high surgical team satisfaction.
Answers are grounded in this paper and cite their sources.
May reduce perioperative opioids while maintaining pain control in orthopedic patients; hypothesis-generating pending randomized trials.
The objective of this quality improvement (QI) project was to assess the impact of an evidence based clinical pharmacist practitioner (CPP) model applied to perioperative pain management by integrating a CPP into the perioperative orthopedic surgery clinical pathway. Secondary objective was to assess the effect of CPP pain management service on surgical team satisfaction. This QI project expanded CPP pain management services for patients who were scheduled for an orthopedic surgery. Surgical provider satisfaction of CPP pain management services was assessed through a provider survey. Pain management recommendations by the Pain CPP were implemented 61% (n = 23/38) of the time by the orthopedic surgeon. The impact of the Pain CPP on perioperative pain management was demonstrated by improvement in the Clinically Aligned Pain Assessment Tool, which was similar in patients where CPP recommendations were accepted compared to surgeon only recommended regimens (p = 0.048). Five orthopedic surgical providers responded to our satisfaction survey, 80% (n = 4/5) strongly agree that a pain management CPP should become a permanent member of the care team. Through an evidence-based CPP model we observed a reduction in quantity of opioid prescribed and morphine equivalent daily dose utilized in patients who underwent an orthopedic surgery.
No takes yet. Share an insight, caveat, or question.
Dakroub et al. (2024) studied Perioperative pain management for orthopedic surgeries (n=38). Clinical pharmacist practitioner (CPP) model vs. Surgeon only recommended regimens was evaluated on Improvement in the Clinically Aligned Pain Assessment Tool (p=0.048). Integration of a clinical pharmacist practitioner into perioperative orthopedic care yielded similar pain assessment improvements compared to surgeon-only regimens (p=0.048) and reduced opioid use.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: